Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 ABCB7 ABCA13 CHD1 ZNFX1 CHD2 BTAF1 DNAH7 DDX46 IQCA1 NAE1 HSP90AB2P ATP2B2 HSPA5 TOP2A PIF1 ACSS3 DNAH11	7.94e-06	614	175	18	GO:0140657
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRG3 GABRA4 GABRA6	1.04e-04	11	175	3	GO:0008503
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCB7 ABCA13 CHD1 CHD2 BTAF1 DNAH7 DDX46 IQCA1 HSP90AB2P ATP2B2 HSPA5 PIF1 DNAH11	1.44e-04	441	175	13	GO:0016887
GeneOntologyMolecularFunction	axon guidance receptor activity	L1CAM PTK7 ROBO2	1.77e-04	13	175	3	GO:0008046
GeneOntologyMolecularFunction	transmembrane transporter activity	GABRG3 MPC2 TRPC4AP ABCB7 ABCA13 TRPC3 SLC19A3 SLC29A2 SLC47A2 SLC30A6 ITPR3 CUL5 SLC9B1 SLC25A36 SLC41A3 SLC17A9 SLC24A2 ANO6 TMEM38A TRPV4 ATP2B2 GABRA4 GABRA6	2.67e-04	1180	175	23	GO:0022857
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPC4AP TRPC3 ITPR3 CUL5 SLC24A2 TRPV4 ATP2B2	3.77e-04	151	175	7	GO:0015085
GeneOntologyMolecularFunction	transporter activity	GABRG3 MPC2 TRPC4AP ABCB7 RHBDF2 ABCA13 TRPC3 SLC19A3 SLC29A2 SLC47A2 SLC30A6 ITPR3 CUL5 SLC9B1 SLC25A36 SLC41A3 SLC17A9 SLC24A2 ANO6 TMEM38A TRPV4 ATP2B2 GABRA4 GABRA6	3.81e-04	1289	175	24	GO:0005215
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRG3 GABRA4 GABRA6	4.90e-04	18	175	3	GO:0022851
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH7 DNAH11	4.90e-04	18	175	3	GO:0008569
GeneOntologyMolecularFunction	metal cation:monoatomic cation antiporter activity	SLC30A6 SLC9B1 SLC41A3 SLC24A2	5.39e-04	43	175	4	GO:0140828
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRG3 GABRA4 GABRA6	5.78e-04	19	175	3	GO:0004890
GeneOntologyMolecularFunction	GABA receptor activity	GABRG3 GABRA4 GABRA6	9.01e-04	22	175	3	GO:0016917
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GABRG3 ANO6 GABRA4 GABRA6	9.59e-04	50	175	4	GO:0099095
GeneOntologyMolecularFunction	calcium channel activity	TRPC4AP TRPC3 ITPR3 CUL5 SLC24A2 TRPV4	9.72e-04	129	175	6	GO:0005262
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	GABRG3 TRPC4AP TRPC3 SLC47A2 SLC30A6 ITPR3 CUL5 SLC9B1 SLC41A3 SLC24A2 ANO6 TMEM38A TRPV4 ATP2B2 GABRA4 GABRA6	1.06e-03	758	175	16	GO:0015318
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	SESTD1 TRPC4AP HTR2B TRPC3 DYSF ITPR3 CUL5 SLC24A2 ANO6 TMEM38A TRPV4 MAIP1 DMD ATP2B2	6.78e-06	392	175	14	GO:0070588
GeneOntologyCellularComponent	leading edge membrane	GABRG3 FERMT1 ROBO2 TRPV4 PLEK USH2A ATP2B2 RASGRP2 GABRA4 GABRA6	1.20e-05	210	176	10	GO:0031256
GeneOntologyCellularComponent	neuron projection membrane	GABRG3 ROBO2 USH2A ATP2B2 GABRA4 GABRA6	6.74e-05	82	176	6	GO:0032589
GeneOntologyCellularComponent	cell projection membrane	GABRG3 FERMT1 ITGA3 ROBO2 TRPV4 DMD PLEK USH2A ATP2B2 RASGRP2 GABRA4 GABRA6	3.04e-04	431	176	12	GO:0031253
GeneOntologyCellularComponent	cell leading edge	GABRG3 FERMT1 DYSF ROBO2 TRPV4 DMD PLEK USH2A ATP2B2 FGD3 RASGRP2 GABRA4 GABRA6	3.30e-04	500	176	13	GO:0031252
GeneOntologyCellularComponent	GABA-A receptor complex	GABRG3 GABRA4 GABRA6	5.15e-04	19	176	3	GO:1902711
Domain	MTMR12-like_C	MTMR10 MTMR11	2.51e-04	3	172	2	IPR022587
Domain	DUF4208	CHD1 CHD2	2.51e-04	3	172	2	PF13907
Domain	DUF4208	CHD1 CHD2	2.51e-04	3	172	2	IPR025260
Domain	3-PAP	MTMR10 MTMR11	2.51e-04	3	172	2	PF12578
Domain	DUF4208	CHD1 CHD2	2.51e-04	3	172	2	SM01176
Domain	Dynein_HC_stalk	DNHD1 DNAH7 DNAH11	2.59e-04	14	172	3	IPR024743
Domain	Myotubularin-like_Pase_dom	MTMR10 MTMR4 MTMR11	2.59e-04	14	172	3	IPR010569
Domain	Dynein_heavy_dom-2	DNHD1 DNAH7 DNAH11	2.59e-04	14	172	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH7 DNAH11	2.59e-04	14	172	3	PF08393
Domain	MT	DNHD1 DNAH7 DNAH11	2.59e-04	14	172	3	PF12777
Domain	PPASE_MYOTUBULARIN	MTMR10 MTMR4 MTMR11	2.59e-04	14	172	3	PS51339
Domain	Myotubularin_fam	MTMR10 MTMR4 MTMR11	2.59e-04	14	172	3	IPR030564
Domain	Myotub-related	MTMR10 MTMR4 MTMR11	2.59e-04	14	172	3	PF06602
Domain	DHC_fam	DNHD1 DNAH7 DNAH11	3.22e-04	15	172	3	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH7 DNAH11	3.22e-04	15	172	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH7 DNAH11	3.22e-04	15	172	3	IPR004273
Pubmed	A forward genetic screen with a thalamocortical axon reporter mouse yields novel neurodevelopment mutants and a distinct emx2 mutant phenotype.	RELN L1CAM EMX2 HSPA5	2.29e-08	7	178	4	21214893
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MTA2 CHD1 CHD2 FRYL PRPF8 TRRAP ITPR3 RIF1 URB1 IARS2 DDX46 RRP9 MKI67 RRP7A PLEC EPB41L2 HERC5	5.12e-08	653	178	17	22586326
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MTA2 SFMBT1 BAZ2B CHD2 RFX7 PRPF8 TRRAP ITPR3 INTS10 RIF1 SETD2 URB1 DDX46 MTA1 RRP9 NFIX INTS11 MKI67 TMEM209 UHRF1 RRP7A HSPA5 TOP2A	2.25e-07	1294	178	23	30804502
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	PGS1 LILRB2 HLA-DRA HMGCR NYNRIN LRP1 PLEC DNAH11	9.29e-07	146	178	8	20686565
Pubmed	Runx1 Transcription Factor Is Required for Myoblasts Proliferation during Muscle Regeneration.	DAPK1 PTGIS MKI67 DMD	1.15e-06	16	178	4	26275053
Pubmed	Choreography of early thalamocortical development.	RELN L1CAM EMX2	1.31e-06	5	178	3	12764042
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MTA2 ABCB7 OAS3 HMGCR BTAF1 PRPF8 ARCN1 POLR3A ITPR3 CUL5 NBAS URB1 IARS2 DDX46 BUB1B MKI67 TMEM209 MAIP1 HSP90AB2P TOP2A HERC5 CCDC93 KPNA3	1.41e-06	1440	178	23	30833792
Pubmed	Discovery and refinement of loci associated with lipid levels.	PGS1 HLA-DRA HMGCR SNX13 SETD2 NYNRIN LRP1 PLEC DNAH11	1.56e-06	211	178	9	24097068
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MTA2 SNX17 FERMT1 OAS3 CHD1 CHD2 PRPF8 TRRAP ARCN1 POLR3A RIF1 URB1 INTS11 MKI67 HSP90AB2P PLEC EIF2AK2 HSPA5 TOP2A EPB41L2 CCDC93 KPNA3	1.83e-06	1353	178	22	29467282
Pubmed	Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss.	ITGA1 ITGA3 F5	4.54e-06	7	178	3	15109703
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	CHD1 PRPF8 ARCN1 RIF1 DDX46 NAE1 BUB1B MKI67 HSP90AB2P DMD ATP2B2 HSPA5 TOP2A	4.56e-06	538	178	13	28524877
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MTA2 CHD1 BTAF1 PRPF8 TRRAP F5 ARCN1 ITPR3 RIF1 URB1 DDX46 RRP9 MKI67 UHRF1 PLEC HSPA5 TOP2A EPB41L2	5.91e-06	1024	178	18	24711643
Pubmed	gamma-Aminobutyric acidA receptors displaying association of gamma 3-subunits with beta 2/3 and different alpha-subunits exhibit unique pharmacological properties.	GABRG3 GABRA4 GABRA6	7.24e-06	8	178	3	8175718
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	FERMT1 OAS3 PRPF8 TRRAP ARCN1 CUL5 STXBP1 BUB1B MKI67 UHRF1 RRP7A	9.57e-06	410	178	11	26949251
Pubmed	Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age.	DYSF MKI67 DMD HSPA5	1.06e-05	27	178	4	37169038
Pubmed	Location of preganglionic neurons is independent of birthdate but is correlated to reelin-producing cells in the spinal cord.	RELN EVX1 EVX2	1.08e-05	9	178	3	15236237
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	BAZ2B ACOX1 CHD1 PRPF8 URB1 RRP9 MKI67 RRP7A PLEC TOP2A	1.11e-05	340	178	10	29478914
Pubmed	Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study.	ITGA3 F5 F13A1	1.54e-05	10	178	3	14706682
Pubmed	The transcription factor gene Nfib is essential for both lung maturation and brain development.	L1CAM NFIX ROBO2 EMX2	1.64e-05	30	178	4	15632069
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MTA2 BAZ2B ARHGEF5 CHD1 CHD2 BTAF1 TRRAP RIF1 MTA1 MKI67 UHRF1 TOP2A ZNF292	1.67e-05	608	178	13	36089195
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MTA2 CHD1 CHD2 PRPF8 TRRAP POLR3A CUL5 RIF1 SETD2 DDX46 MTA1 NAE1 MKI67 UHRF1 PLEC EIF2AK2 TOP2A	1.99e-05	1014	178	17	32416067
Pubmed	Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.	MTA2 MKI67	2.60e-05	2	178	2	26722504
Pubmed	Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice.	PHEX DMD	2.60e-05	2	178	2	8691720
Pubmed	Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.	DYSF DMD	2.60e-05	2	178	2	27834955
Pubmed	Histone methyltransferase SETD2 is required for meiotic maturation in mouse oocyte.	SETD2 BUB1B	2.60e-05	2	178	2	30078214
Pubmed	Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.	MKI67 TOP2A	2.60e-05	2	178	2	27175798
Pubmed	Integrin alpha1 localization in murine central and peripheral nervous system.	RELN ITGA1	2.60e-05	2	178	2	9603370
Pubmed	The value of immunohistochemical determination of topoisomerase IIα and Ki67 as markers of cell proliferation and malignant transformation in colonic mucosa.	MKI67 TOP2A	2.60e-05	2	178	2	24185119
Pubmed	Halofuginone promotes satellite cell activation and survival in muscular dystrophies.	DYSF DMD	2.60e-05	2	178	2	26454207
Pubmed	Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma.	DYSF DMD	2.60e-05	2	178	2	22682622
Pubmed	Markers of proliferation and invasiveness in somatotropinomas.	MKI67 TOP2A	2.60e-05	2	178	2	29334118
Pubmed	Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury.	DYSF DMD	2.60e-05	2	178	2	17607357
Pubmed	SNP-PCR genotyping links alterations in the GABAA receptor (GABRG3: rs208129) and RELN (rs73670) genes to autism spectrum disorder among peadiatric Iraqi Arabs.	GABRG3 RELN	2.60e-05	2	178	2	35403940
Pubmed	ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.	UHRF1 TOP2A	2.60e-05	2	178	2	10646863
Pubmed	Partial USH2A deletions contribute to Usher syndrome in Denmark.	PCDH15 USH2A	2.60e-05	2	178	2	25804404
Pubmed	[Pathophysiological roles of transient receptor potential channels in glial cells].	TRPC3 TRPV4	2.60e-05	2	178	2	20190511
Pubmed	Transient Receptor Potential Vanilloid 4 Regulation of Adenosine Triphosphate Release by the Adenosine Triphosphate Transporter Vesicular Nucleotide Transporter, a Novel Therapeutic Target for Gastrointestinal Baroreception and Chronic Inflammation.	SLC17A9 TRPV4	2.60e-05	2	178	2	31770754
Pubmed	Changes in integrin expression during chondrogenesis in vitro: an immunomorphological study.	ITGA1 ITGA3	2.60e-05	2	178	2	7560884
Pubmed	Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.	DYSF DMD	2.60e-05	2	178	2	19286669
Pubmed	TRPC3 determines osmosensitive [Ca2+]i signaling in the collecting duct and contributes to urinary concentration.	TRPC3 TRPV4	2.60e-05	2	178	2	31851715
Pubmed	Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy.	DYSF DMD	2.60e-05	2	178	2	26206886
Pubmed	Single-cell transcriptomic analysis of the identity and function of fibro/adipogenic progenitors in healthy and dystrophic muscle.	DYSF DMD	2.60e-05	2	178	2	37599828
Pubmed	Isolation and mapping of EVX1, a human homeobox gene homologous to even-skipped, localized at the 5' end of HOX1 locus on chromosome 7.	EVX1 EVX2	2.60e-05	2	178	2	1684419
Pubmed	CHD1 and CHD2 are positive regulators of HIV-1 gene expression.	CHD1 CHD2	2.60e-05	2	178	2	25297984
Pubmed	Involvement of VNUT-exocytosis in transient receptor potential vanilloid 4-dependent ATP release from gastrointestinal epithelium.	SLC17A9 TRPV4	2.60e-05	2	178	2	30365528
Pubmed	Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation.	MTA2 MTA1	2.60e-05	2	178	2	30642362
Pubmed	Assignment of the metastasis-associated gene (Mta1) to mouse chromosome band 12F and the metastasis-associated gene 2 (Mta2) to mouse chromosome band 19B by fluorescence in situ hybridization.	MTA2 MTA1	2.60e-05	2	178	2	11856890
Pubmed	Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice.	DYSF DMD	2.60e-05	2	178	2	22132688
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TRPC4AP ZNFX1 CHD2 ITGA3 DNAH7 ITPR3 STXBP1 MEGF8 RRP7A MAIP1 WDR17 ACSS3 DNAH11	2.76e-05	638	178	13	31182584
Pubmed	Dbx1 triggers crucial molecular programs required for midline crossing by midbrain commissural axons.	EVX1 EVX2 MKI67	2.80e-05	12	178	3	24553291
Pubmed	Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.	MTMR10 MTMR4 MTMR11	2.80e-05	12	178	3	16787938
Pubmed	Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice.	HTR2B GABRA4 GABRA6	3.63e-05	13	178	3	22569571
Pubmed	Emx1 and Emx2 cooperate to regulate cortical size, lamination, neuronal differentiation, development of cortical efferents, and thalamocortical pathfinding.	RELN L1CAM EMX2	3.63e-05	13	178	3	12561075
Pubmed	Slc25a17 Gene Trapped Mice: PMP34 Plays a Role in the Peroxisomal Degradation of Phytanic and Pristanic Acid.	CYP4A11 ACOX1 HMGCR	3.63e-05	13	178	3	32266253
Pubmed	Identification and characterization of nardilysin as a novel dimethyl H3K4-binding protein involved in transcriptional regulation.	NRDC MTA1 UHRF1	3.63e-05	13	178	3	22294699
Pubmed	Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning.	HTR2B GABRA4 GABRA6	3.63e-05	13	178	3	22640814
Pubmed	Absence of Cajal-Retzius cells and subplate neurons associated with defects of tangential cell migration from ganglionic eminence in Emx1/2 double mutant cerebral cortex.	RELN L1CAM EMX2	3.63e-05	13	178	3	12091317
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SFMBT1 ABCB7 ZNF268 SNX17 BTAF1 PRPF8 TRRAP RIF1 IARS2 MTA1 ZFHX4 NFIX LRP1 TOP2A HERC5	3.83e-05	857	178	15	25609649
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MTA2 PRPF8 TRRAP ARCN1 RIF1 URB1 DDX46 RRP9 MKI67 UHRF1 RRP7A EIF2AK2 TOP2A HERC5	3.99e-05	759	178	14	35915203
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	MTA2 SFMBT1 BAZ2B DNAH7 MTA1	4.29e-05	75	178	5	25593309
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	MTA2 CHD1 PRPF8 RIF1 URB1 RRP9 MKI67 RRP7A TOP2A HERC5 KPNA3	4.30e-05	483	178	11	36912080
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 DNHD1 NRDC CHD1 PRPF8 ARCN1 POLR3A RIF1 URB1 IARS2 RRP9 INTS11 MKI67 COPS4 UHRF1 RRP7A EIF2AK2 HSPA5 TOP2A EPB41L2	4.56e-05	1425	178	20	30948266
Pubmed	Dystroglycan organizes axon guidance cue localization and axonal pathfinding.	L1CAM ROBO2 GABRA6	4.60e-05	14	178	3	23217742
Pubmed	Mutation of the BiP/GRP78 gene causes axon outgrowth and fasciculation defects in the thalamocortical connections of the mammalian forebrain.	RELN L1CAM HSPA5	4.60e-05	14	178	3	22821687
Pubmed	Emx2 in the developing hippocampal fissure region.	RELN MKI67 EMX2	4.60e-05	14	178	3	16819978
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	CHD1 TRRAP RIF1 SETD2 MKI67 RRP7A HSPA5 TOP2A	4.75e-05	250	178	8	33536335
Pubmed	Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System.	RELN MKI67 ROBO2	5.73e-05	15	178	3	27667971
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	TRPC4AP ITPR3 TMEM132C MKI67 HYDIN	5.85e-05	80	178	5	19389623
Pubmed	Tagging genes with cassette-exchange sites.	MPV17L RFX7 DYSF RIF1 DDX46 TET1 MKI67 PLEC ZNF292	6.21e-05	335	178	9	15741177
Pubmed	Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues.	L1CAM STXBP1 ATP2B2 HSPA5	6.38e-05	42	178	4	15146195
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	BTAF1 DNAH7 MTMR10 PTK7 EYS MTMR11 LRP1 CES4A HSPA5 EPB41L2	6.67e-05	420	178	10	28065597
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	MTA2 BTAF1 PRPF8 TRRAP DDX46 MTA1 TOP2A	6.95e-05	195	178	7	19454010
Pubmed	Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.	MTA2 PRPF8 COPS4 TOP2A	7.00e-05	43	178	4	26030138
Pubmed	Intestinal SURF4 is essential for apolipoprotein transport and lipoprotein secretion.	HMGCR MKI67 HSPA5	7.03e-05	16	178	3	38042368
Pubmed	Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.	DYSF DMD	7.79e-05	3	178	2	31852847
Pubmed	Role of Emx2 in the development of the reciprocal connectivity between cortex and thalamus.	L1CAM EMX2	7.79e-05	3	178	2	12209834
Pubmed	Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration.	NFIX DMD	7.79e-05	3	178	2	29057908
Pubmed	Impaired postnatal development of hippocampal neurons and axon projections in the Emx2-/- mutants.	RELN EMX2	7.79e-05	3	178	2	12437591
Pubmed	Three-dimensional mapping reveals heterochronic development of the neuromuscular system in postnatal mouse skeletal muscles.	MKI67 DMD	7.79e-05	3	178	2	36347940
Pubmed	Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.	F5 LRP1	7.79e-05	3	178	2	17155964
Pubmed	Identification and characterization of metastasis-associated gene/protein 1 (MTA1).	MTA2 MTA1	7.79e-05	3	178	2	25315816
Pubmed	Expression of beta 1 integrins in human dental pulp in vivo: a comparative immunohistochemical study on healthy and chronic marginal periodontitis samples.	ITGA1 ITGA3	7.79e-05	3	178	2	11307375
Pubmed	CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.	CHD1 CHD2	7.79e-05	3	178	2	33022763
Pubmed	Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.	F5 F13A1	7.79e-05	3	178	2	19783216
Pubmed	DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.	MKI67 TOP2A	7.79e-05	3	178	2	28301542
Pubmed	Ontogeny of the cell adhesion molecule L1 in the cerebellum of weaver and reeler mutant mice.	RELN L1CAM	7.79e-05	3	178	2	7969746
Pubmed	Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.	F5 F13A1	7.79e-05	3	178	2	12480694
Pubmed	Cullin 5 regulates cortical layering by modulating the speed and duration of Dab1-dependent neuronal migration.	RELN CUL5	7.79e-05	3	178	2	20410119
Pubmed	Next-generation sequencing to solve complex inherited retinal dystrophy: A case series of multiple genes contributing to disease in extended families.	PRPF8 USH2A	7.79e-05	3	178	2	28761320
Pubmed	Polymorphisms of haemostasis genes as risk factors for preterm delivery.	F5 F13A1	7.79e-05	3	178	2	16113789
Pubmed	Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.	F5 F13A1	7.79e-05	3	178	2	17582472
Pubmed	ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.	MTA1 ZFHX4	7.79e-05	3	178	2	24440720
Pubmed	Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.	MKI67 TOP2A	7.79e-05	3	178	2	27284123
Pubmed	Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.	MKI67 TOP2A	7.79e-05	3	178	2	27259241
Pubmed	Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.	MKI67 TOP2A	7.79e-05	3	178	2	23135572
Pubmed	Molecular and functional diversity of the expanding GABA-A receptor gene family.	GABRG3 GABRA4	7.79e-05	3	178	2	10414349
Pubmed	Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.	DYSF DMD	7.79e-05	3	178	2	18276788
Pubmed	Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.	DYSF DMD	7.79e-05	3	178	2	21060153
Pubmed	Structure, expression and functions of MTA genes.	MTA2 MTA1	7.79e-05	3	178	2	26869315
Pubmed	A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice.	DYSF DMD	7.79e-05	3	178	2	29771357
Cytoband	10q22-q23	BTAF1 POLR3A	1.48e-04	5	178	2	10q22-q23
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR10 MTMR4 MTMR11	1.48e-04	15	128	3	903
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRG3 GABRA4 GABRA6	3.09e-04	19	128	3	563
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	DNHD1 PGS1 CHD2 BTAF1 TRRAP ITPR3 MKI67 DMD CCDC93	4.73e-06	184	177	9	M19988
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	FERMT1 PRPF8 TRRAP MTMR4 DDX46 BUB1B MKI67 PLEC EIF2AK2 TOP2A	8.30e-06	250	177	10	M11318
Coexpression	GSE22886_CTRL_VS_LPS_24H_DC_DN	RHBDF2 RIPK2 OAS3 RTP4 TBC1D8 SLAMF7 LY75 EIF2AK2 HERC5	9.28e-06	200	177	9	M4520
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SFMBT1 BAZ2B DAPK1 CHD1 FRYL BTAF1 TRRAP SNX13 NBAS RIF1 SETD2 BUB1B N4BP1 DMD TOP2A CCDC93 ZNF292 KPNA3	2.14e-05	856	177	18	M4500
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	CRYBG2 TRPC3 OLFM4 NCOA4 F13A1 POLR3A PHEX INTS10 MTMR4 IQCA1 TET1 MDH1B SORCS3 DMD WDR17 FGD3 HERC5 ACSS3	2.77e-05	873	177	18	M16009
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	BAZ2B CHD1 FRYL RIF1 SLC25A36 BUB1B MKI67 N4BP1 TOP2A CCDC93	3.97e-05	300	177	10	M8702
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 FAT3 PKHD1L1 ZFHX4 SLC24A2 PCDH15 DMD USH2A HYDIN DNAH11	1.22e-11	184	178	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 FAT3 PKHD1L1 ZFHX4 SLC24A2 PCDH15 DMD USH2A HYDIN DNAH11	1.22e-11	184	178	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 FAT3 PKHD1L1 ZFHX4 SLC24A2 PCDH15 DMD USH2A HYDIN DNAH11	1.22e-11	184	178	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	BAZ2B OAS3 ZNFX1 CHD2 RIF1 SETD2 N4BP1 EIF2AK2 HERC5 ZNF292	3.65e-09	183	178	10	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCA13 DNAH7 TBC1D8 SLC25A36 IQCA1 NFIX CES4A HYDIN CFAP46 DNAH11	6.09e-09	193	178	10	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 FAT3 PKHD1L1 PCDH15 SORCS3 USH2A ATP2B2 HYDIN DNAH11	2.81e-08	169	178	9	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 ABCA13 MPV17L DNAH7 SLC47A2 TBC1D8 HYDIN CFAP46 DNAH11	4.84e-08	180	178	9	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PTK7 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	8.42e-08	192	178	9	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	FERMT1 OMG ABHD4 BUB1B MKI67 PCDH15 UHRF1 TOP2A EPB41L2	1.19e-07	200	178	9	02594c1edbc9f2cf831639cd83363abd2551cb94
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	OAS3 CHD1 CHD2 FRYL BTAF1 SETD2 EIF2AK2 HERC5 ZNF292	1.19e-07	200	178	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	FERMT1 OMG ABHD4 BUB1B MKI67 PCDH15 UHRF1 TOP2A EPB41L2	1.19e-07	200	178	9	46521d83b917b0357601db8783c8da6b73730d60
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	BAZ2B ITGA1 PTK7 TMEM132C ZFHX4 SPHKAP LRP1 ROBO2 DMD	1.19e-07	200	178	9	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	BAZ2B ITGA1 PTK7 TMEM132C ZFHX4 SPHKAP LRP1 ROBO2 DMD	1.19e-07	200	178	9	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN FAT3 EYS PCDH15 ROBO2 DMD USH2A	2.61e-07	159	178	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 FAT3 F5 PKHD1L1 PCDH15 CES4A USH2A HYDIN	3.01e-07	162	178	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN TMEM132C EYS PCDH15 ROBO2 DMD USH2A	3.16e-07	163	178	8	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D30 ZCCHC10 OAS3 ITPR3 SLC17A9 MKI67 FGD3 ZNF287	5.19e-07	174	178	8	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D30 ZCCHC10 OAS3 ITPR3 SLC17A9 MKI67 FGD3 ZNF287	5.19e-07	174	178	8	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	6.71e-07	180	178	8	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN FAT3 EYS PCDH15 ROBO2 DMD	8.97e-07	129	178	7	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	9.69e-07	189	178	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 PTK7 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	1.01e-06	190	178	8	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	1.05e-06	191	178	8	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LAM-Epithelial-AirwayEpi\|LAM / Condition, Lineage and Cell class	DNAH7 OMG IQCA1 RHOV MDH1B HYDIN CFAP46 DNAH11	1.09e-06	192	178	8	7404fc65be3b7bd09447725b43fa31819004dfee
ToppCell	NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRB2 HLA-DRA RIPK2 OAS3 PLEK SLAMF7 EIF2AK2 HERC5	1.13e-06	193	178	8	0dd83b21e164147abfd511a927615c40a28781a2
ToppCell	ASK440-Epithelial-Ciliated\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	NPHP1 ABCA13 DNAH7 OMG IQCA1 MDH1B HYDIN DNAH11	1.13e-06	193	178	8	a0baa8be6f590b2031fede22be588715ae458e93
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3 DMD ACSS3	1.18e-06	194	178	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 ABCA13 DNAH7 MDH1B CES4A HYDIN CFAP46 DNAH11	1.18e-06	194	178	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LILRB2 HLA-DRA RIPK2 OAS3 RTP4 SLAMF7 EIF2AK2 HERC5	1.18e-06	194	178	8	e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GABRG3 SDK2 FAT3 ITGA1 PHEX TMEM132C PCDH15 ROBO2	1.18e-06	194	178	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3 ACSS3	1.18e-06	194	178	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	NPHP1 ABCA13 DNAH7 OMG IQCA1 HYDIN CFAP46 DNAH11	1.18e-06	194	178	8	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.23e-06	195	178	8	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 ABCA13 MPV17L DNAH7 TBC1D8 HYDIN CFAP46 DNAH11	1.23e-06	195	178	8	79dc031258579ea328181dda33710dd897f1064a
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FRYL HMGCR RIF1 STXBP1 SLC24A2 SPHKAP ROBO2	1.23e-06	195	178	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NPHP1 DNAH7 IQCA1 MDH1B CES4A HYDIN CFAP46 DNAH11	1.23e-06	195	178	8	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.27e-06	196	178	8	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.27e-06	196	178	8	69f5081e06d84ec1d9695762df801a9d0df1984b
ToppCell	CV-Moderate-1\|Moderate / Virus stimulation, Condition and Cluster	OAS3 ZNFX1 RTP4 N4BP1 PLEK SLAMF7 EIF2AK2 HERC5	1.27e-06	196	178	8	b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.27e-06	196	178	8	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.27e-06	196	178	8	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NPHP1 DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.27e-06	196	178	8	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	CV-Moderate-1\|CV / Virus stimulation, Condition and Cluster	OAS3 ZNFX1 RTP4 N4BP1 PLEK SLAMF7 EIF2AK2 HERC5	1.32e-06	197	178	8	e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 IQCH DNAH7 MDH1B DMD HYDIN CFAP46 DNAH11	1.32e-06	197	178	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BAZ2B PTK7 TMEM132C ZFHX4 SPHKAP LRP1 ROBO2 DMD	1.43e-06	199	178	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 HMGCR PTK7 PHEX TMEM132C PCDH15 LRP1 SORCS3	1.43e-06	199	178	8	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	NPHP1 DNAH7 OMG MDH1B CES4A HYDIN CFAP46 DNAH11	1.48e-06	200	178	8	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPHP1 ABCA13 DNAH7 OMG MDH1B HYDIN CFAP46 DNAH11	1.48e-06	200	178	8	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	MS-IIF-Lymphocyte-T/NK-dn_T\|IIF / Disease, condition lineage and cell class	SESTD1 ABCA13 RTP4 OMG TET1 MKI67 TOP2A ACSS3	1.48e-06	200	178	8	c34fff02992cba6bcc2308019cb00b94e1227300
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Ciliated\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	NPHP1 ABCA13 DNAH7 OMG MDH1B HYDIN CFAP46 DNAH11	1.48e-06	200	178	8	d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NPHP1 ABCA13 DNAH7 OMG MDH1B HYDIN CFAP46 DNAH11	1.48e-06	200	178	8	cf59110547cc66b5f4a2999735336b0309ba9b0d
ToppCell	COVID_non-vent\|World / Disease condition, Lineage, Cell class and subclass	LILRB2 HLA-DRA OAS3 DYSF F13A1 LRP1 EIF2AK2 HERC5	1.48e-06	200	178	8	accef1050963dc91e189ac3d38228f15bf57e06e
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KBTBD6 BUB1B MKI67 UHRF1 TOP2A PIF1 DNAH11	1.71e-06	142	178	7	328d08ba2712cd42bb9846ac4d7453ae165b75e2
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KBTBD6 BUB1B MKI67 UHRF1 TOP2A PIF1 DNAH11	1.71e-06	142	178	7	92bf826827b3e3387ad326566556fc90c5c2f4d5
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KBTBD6 BUB1B MKI67 UHRF1 TOP2A PIF1 DNAH11	1.71e-06	142	178	7	7bd05d0c0ac2dee0e6cc0f3c531f9154bf300c75
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	KBTBD6 BUB1B MKI67 UHRF1 TOP2A PIF1 DNAH11	1.71e-06	142	178	7	94774d3e598d074f48146b0b094705dc48af5a1f
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN ABCA13 EYS PCDH15 ROBO2 USH2A	2.06e-06	146	178	7	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	IIF-Lymphocyte-T_NK-dnT\|IIF / Disease, Lineage and Cell Type	SESTD1 ABCA13 RTP4 OMG MKI67 TOP2A ACSS3	2.06e-06	146	178	7	d0f361662db5f7be26104346e8431f7e30c5ce3a
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN EYS PCDH15 SORCS3 USH2A ATP2B2	2.46e-06	150	178	7	0205318a870e091add66ee4305747dda9f51510d
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH DNAH7 MDH1B USH2A HYDIN CFAP46 DNAH11	2.93e-06	154	178	7	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH DNAH7 MDH1B USH2A HYDIN CFAP46 DNAH11	2.93e-06	154	178	7	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH DNAH7 MDH1B TRPV4 HYDIN CFAP46 DNAH11	3.06e-06	155	178	7	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH DNAH7 MDH1B TRPV4 HYDIN CFAP46 DNAH11	3.06e-06	155	178	7	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SESTD1 L1CAM ITGA1 F13A1 NLRC4 SLAMF7 RASGRP2	3.20e-06	156	178	7	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 PKHD1L1 ZFHX4 SPHKAP WDR17 USH2A HYDIN	3.78e-06	160	178	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	RHBDF2 SLC19A3 RTP4 ITPR3 TRPV4 LY75 C16orf54	3.78e-06	160	178	7	04714d0b9bad4c11fa193ed168e2d84a4df39e2e
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 PKHD1L1 ZFHX4 SPHKAP WDR17 USH2A HYDIN	3.78e-06	160	178	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Lung-nan-18m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 RELN PLCXD1 NBAS RASSF6 MKI67 SLAMF7	4.27e-06	163	178	7	5efecdd8a069a822bc9d35b407092925a865e629
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 RELN PLCXD1 NBAS RASSF6 MKI67 SLAMF7	4.27e-06	163	178	7	0d94a427f86e62aba12c397c6d7b8cd297f3a0e5
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 RELN PLCXD1 NBAS RASSF6 MKI67 SLAMF7	4.45e-06	164	178	7	b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 RELN PLCXD1 NBAS RASSF6 MKI67 SLAMF7	4.45e-06	164	178	7	a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCell	droplet-Lung-LUNG-30m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFMBT1 OMG TBC1D8 MTMR4 UHRF1 SLAMF7 LY75	5.21e-06	168	178	7	0e8b0e6399c6c82c9c0e546f7316f902de0765d3
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPHP1 DNAH7 MDH1B WDR17 HYDIN CFAP46 DNAH11	5.42e-06	169	178	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRG3 RELN CPB1 EYS SLC24A2 PCDH15 ATP2B2	5.85e-06	171	178	7	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NPHP1 ABCA13 DNAH7 OMG IQCA1 MDH1B HYDIN	6.08e-06	172	178	7	187ae91148d293537afc77e10da2b64302322224
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SFMBT1 PLCXD1 FERMT1 RFX7 SLC25A36 NYNRIN PIF1	6.08e-06	172	178	7	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SFMBT1 PLCXD1 FERMT1 RFX7 SLC25A36 NYNRIN PIF1	6.08e-06	172	178	7	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BUB1B MKI67 UHRF1 PLEK SLAMF7 TOP2A PIF1	6.56e-06	174	178	7	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	OTOA OAS3 ZNFX1 RTP4 N4BP1 EIF2AK2 HERC5	7.89e-06	179	178	7	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	ASK454-Epithelial-Ciliated\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NPHP1 SFMBT1 ABCA13 OMG MDH1B COPS4 HYDIN	7.89e-06	179	178	7	f21919ef9d3d984e2925ef3d24f89e20fe265dcd
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NRDC OAS3 SPHKAP HAS3 SLAMF7 EIF2AK2	8.05e-06	118	178	6	5f72022f4be3fb7ccec86dc05d37572833028886
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NRDC OAS3 SPHKAP HAS3 SLAMF7 EIF2AK2	8.05e-06	118	178	6	053c0986051e36fdc4c48b8067c137b6299b2f1b
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 FAT3 PHEX TMEM132C PCDH15 LRP1 SORCS3	8.18e-06	180	178	7	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6-Excitatory_NeuronSlc17a7-Slc17a6.Syt6-Nnat_(Deep_layer_pyramidal_cells--medial_cortex)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	OTOA IQCH OAS3 IQCA1 GABRA6	8.39e-06	69	178	5	de297aa59c70f15c55cb9570439dc6d3fd6c182b
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	OTOA IQCH OAS3 IQCA1 GABRA6	8.39e-06	69	178	5	31f4fb56dfa5e3ad7c83e0770960c3617e4f66a7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRDC OAS3 SPHKAP HAS3 SLAMF7 EIF2AK2	8.45e-06	119	178	6	0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2
ToppCell	Control-Lymphoid_T/NK-NK_activated\|Control / Disease group, lineage and cell class	NRDC OAS3 SPHKAP HAS3 SLAMF7 EIF2AK2	8.45e-06	119	178	6	a258d91ac90d4174b6f203d7f96ba6e57c6003e7
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRDC OAS3 SPHKAP HAS3 SLAMF7 EIF2AK2	8.45e-06	119	178	6	28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHBDF2 LILRB2 HLA-DRA F13A1 TBC1D8 PLEK C16orf54	8.49e-06	181	178	7	090e89b506d945e123e647d08947e9649a65ce7c
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DAPK1 CPB1 ITGA3 PTGIS IQCA1 SPHKAP PCDH15	8.49e-06	181	178	7	7679a5980011d6dfb1aaca7abf678c29b6f819bb
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DAPK1 CPB1 ITGA3 PTGIS IQCA1 SPHKAP PCDH15	8.49e-06	181	178	7	3dcb74b28f93be35ddf4de1937f7e30b25e11927
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 F5 TBC1D8 BUB1B MKI67 LY75 TOP2A	8.49e-06	181	178	7	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 F5 TBC1D8 BUB1B MKI67 LY75 TOP2A	8.49e-06	181	178	7	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BUB1B MKI67 PLEK LY75 TUBE1 TOP2A PIF1	8.80e-06	182	178	7	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPHP1 HMGCR PTK7 BUB1B MKI67 TOP2A PIF1	8.80e-06	182	178	7	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 FAT3 DAPK1 DNAH7 MTMR10 HYDIN DNAH11	9.45e-06	184	178	7	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NPHP1 DNAH7 IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.01e-05	186	178	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	OTOA BUB1B MKI67 UHRF1 TOP2A PIF1 HERC5	1.01e-05	186	178	7	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B-GC_B_(I)\|GI_small-bowel / Manually curated celltypes from each tissue	NPHP1 HLA-DRA BUB1B MKI67 MDH1B UHRF1 TOP2A	1.05e-05	187	178	7	a92cade2a835f5fce8de1e14650af8cdd818c296
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH7 OMG IQCA1 MDH1B HYDIN CFAP46 DNAH11	1.12e-05	189	178	7	dc440015949a768188c67661b6be63b1ead1a0f0
Drug	Me-lex	GABRG3 HMGCR GABRA4 GABRA6	3.25e-06	14	176	4	CID000004177
Drug	oxazepam	GABRG3 CYP4A11 UGT2A1 HAS3 GABRA4 GABRA6	3.33e-06	53	176	6	CID000004616
Drug	2-nitroimidazole	PDE1B L1CAM SLC29A2 RIF1 DMD SLAMF7 TUBE1 USH2A	7.48e-06	129	176	8	CID000010701
Drug	AC1N65YL	GABRG3 HTR2B GABRA4 GABRA6	1.52e-05	20	176	4	CID004229818
Drug	3 -hydroxypregn-5-en-20-one	GABRG3 CYP4A11 HMGCR PTGIS UGT2A1 PLEC HAS3 HSPA5 GABRA4 GABRA6	1.72e-05	238	176	10	CID000001027
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	TBC1D30 LILRB2 SLC19A3 PTGIS RIF1 MTA1 LRP1 SLAMF7 ATP2B2	1.93e-05	192	176	9	4268_UP
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A	CRYBG2 LILRB2 TRPC3 F5 SLC29A2 OMG ZNF117 LRP1 RASGRP2	2.10e-05	194	176	9	4269_UP
Drug	imidazenil	GABRG3 RELN GABRA4 GABRA6	2.26e-05	22	176	4	CID000119194
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	MTA2 RELN INHBC DAPK1 OMG F13A1 PTK7 URB1 RASGRP2	2.28e-05	196	176	9	4361_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	IQCH PTGIS F13A1 MEGF8 TRPV4 SLAMF7 ATP2B2 ACSS3 RASGRP2	2.47e-05	198	176	9	4428_UP
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	MTA2 INHBC LILRB2 SLC19A3 CPB1 F13A1 SNX13 ITPR3 PLEK	2.57e-05	199	176	9	4362_UP
Drug	adinazolam	GABRG3 HTR2B GABRA4 GABRA6	2.72e-05	23	176	4	CID000037632
Drug	2 6a	SLC29A2 NLRC4 PTK7 SLAMF7	2.72e-05	23	176	4	CID010062690
Drug	delta-aminovaleric acid	GABRG3 F5 PCDH15 GABRA4 GABRA6	3.08e-05	47	176	5	CID000000138
Drug	Epirubicin	CHD1 TOP2A	5.94e-05	2	176	2	DB00445
Drug	hexobarbital	GABRG3 CYP4A11 PTGIS UGT2A1 HAS3 GABRA4 GABRA6	6.00e-05	127	176	7	CID000003608
Drug	fosazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000037114
Drug	C19H18ClN3O	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000027452
Drug	flutoprazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000003400
Drug	Arfendazam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000065803
Drug	camazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000037367
Drug	Bu-1014	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID015942721
Drug	Zapizolam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000068832
Drug	Reclazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID003052777
Drug	iclazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000068777
Drug	menitrazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000189875
Drug	Serin hydrazid	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000041637
Drug	sulazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000017931
Drug	elfazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000065445
Drug	triflubazam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000031157
Drug	uldazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000034274
Drug	gidazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000121919
Drug	fletazepam	GABRG3 GABRA4 GABRA6	7.16e-05	11	176	3	CID000036834
Drug	SB-205384	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000197690
Drug	U-93631	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000197626
Drug	haloxazolam	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000003563
Drug	doxefazepam	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000038668
Drug	pivoxazepam	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000068722
Drug	razobazam	GABRG3 GABRA4 GABRA6	9.49e-05	12	176	3	CID000071228
Drug	nerisopam	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000065875
Drug	flutazolam	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000003398
Drug	4-PIOL	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000125520
Drug	AC1MVFYM	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID003707225
Drug	Ro 11-3128	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000093364
Drug	cinolazepam	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID003033621
Drug	alpha IMGBL	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000131516
Drug	metaclazepam	GABRG3 GABRA4 GABRA6	1.23e-04	13	176	3	CID000071272
Disease	Embryonal Rhabdomyosarcoma	SETD2 BUB1B DMD	1.07e-05	8	172	3	C0206656
Disease	blood cobalt measurement	F5 EYS ROBO2 MAIP1 PLEK USH2A	2.88e-05	101	172	6	EFO_0007577
Disease	pentachlorophenol measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022071
Disease	parathion measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022070
Disease	potassium chromate measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022072
Disease	mercuric chloride measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022068
Disease	heptachlor epoxide measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022067
Disease	methoxychlor measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022052
Disease	azinphos methyl measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022055
Disease	aldrin measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022054
Disease	dicofol measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022060
Disease	disulfoton measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022062
Disease	dieldrin measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022061
Disease	endrin measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022064
Disease	endosulfan measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022063
Disease	heptachlor measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022066
Disease	ethion measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022065
Disease	chlorpyrifos measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022057
Disease	cadmium chloride measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022056
Disease	diazinon measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022059
Disease	dibutyl phthalate measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0022058
Disease	environmental exposure measurement	F5 EYS MAIP1 PLEK USH2A	6.92e-05	73	172	5	EFO_0008360
Disease	DDT metabolite measurement	F5 EYS MAIP1 PLEK USH2A	7.39e-05	74	172	5	EFO_0007886
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	DAPK1 INTS10 ROBO2 DMD	7.82e-05	39	172	4	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	Tremor, Rubral	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0750940
Disease	Ataxia, Appendicular	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0750937
Disease	Ataxia, Motor	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0278161
Disease	Ataxia, Sensory	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0240991
Disease	Abnormal coordination	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0520966
Disease	Ataxia, Truncal	ABCB7 ARCN1 GABRA4	1.03e-04	16	172	3	C0427190
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	DAPK1 INTS10 EYS ROBO2	1.05e-04	42	172	4	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 SETD2 ZNF292	1.25e-04	17	172	3	DOID:0060307 (is_implicated_in)
Disease	bipolar disorder (is_marker_for)	RELN HLA-DRA L1CAM	1.76e-04	19	172	3	DOID:3312 (is_marker_for)
Disease	pulse pressure measurement	IQCH NBEAL1 ACOX1 FAT3 CHD2 FRYL ITGA1 DYSF ZFHX4 MEGF8 TET1 ASB3 UGT2A1 INTS11 LRP1 UHRF1 SORCS3 HYDIN PIF1 GABRA6	1.88e-04	1392	172	20	EFO_0005763
Disease	Neurodevelopmental Disorders	CHD2 PTK7 SETD2 STXBP1 ZNF292	2.18e-04	93	172	5	C1535926
Disease	total lipids in medium LDL	SNX17 HMGCR ITGA1 NYNRIN	2.43e-04	52	172	4	EFO_0022180
Disease	Influenza	OAS3 RTP4 EIF2AK2 HERC5	2.43e-04	52	172	4	C0021400
Disease	pulmonary embolism (is_implicated_in)	F5 F13A1	3.34e-04	5	172	2	DOID:9477 (is_implicated_in)
Disease	hearing threshold measurement, pure tone hearing measurement	TBC1D8 TRPV4	3.34e-04	5	172	2	EFO_0007617, EFO_0007618
Disease	vesicoureteral reflux (is_implicated_in)	AGTR2 ROBO2	3.34e-04	5	172	2	DOID:9620 (is_implicated_in)
Disease	Usher Syndrome, Type II	PCDH15 USH2A	3.34e-04	5	172	2	C1568249
Disease	Ataxia	ABCB7 ARCN1 GABRA4	4.07e-04	25	172	3	C0004134
Disease	methionine measurement	TRPC3 ZNF285 PCDH15	4.58e-04	26	172	3	EFO_0009771
Disease	adipoylcarnitine (C6-DC) measurement	CYP4A11 ACOX1	4.99e-04	6	172	2	EFO_0800380
Disease	retinitis pigmentosa (implicated_via_orthology)	PRPF8 EYS USH2A	5.14e-04	27	172	3	DOID:10584 (implicated_via_orthology)
Disease	diffuse plaque measurement	RELN SDK2 NRDC ABCA13 DAPK1 F13A1 EVX2 EYS ASB3 ROBO2 HSP90AB2P EIF2AK2 DNAH11	5.30e-04	758	172	13	EFO_0010699
Disease	muscular atrophy (biomarker_via_orthology)	MTMR4 HSP90AB2P DMD	6.36e-04	29	172	3	DOID:767 (biomarker_via_orthology)
Disease	Microcephaly	TRRAP TSEN2 BUB1B ZNF292	6.42e-04	67	172	4	C0025958
Disease	N4-acetylcytidine measurement	SLC47A2 EMX2	6.96e-04	7	172	2	EFO_0800628
Disease	myoclonic-atonic epilepsy (implicated_via_orthology)	CHD2 ROBO2	6.96e-04	7	172	2	DOID:0060475 (implicated_via_orthology)
Disease	blood nickel measurement	F5 EYS MAIP1 PLEK USH2A	7.05e-04	120	172	5	EFO_0007583
Disease	Thrombophilia due to thrombin defect	F5 F13A1	9.24e-04	8	172	2	cv:C3160733
Disease	response to bronchodilator	ASB3 MAIP1	9.24e-04	8	172	2	GO_0097366
Disease	prostate cancer (implicated_via_orthology)	CHD1 CHD2 PRPF8	9.34e-04	33	172	3	DOID:10283 (implicated_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	PGS1 NRDC HMGCR ITGA1 ZNF285 ARCN1 TBC1D8 INTS10 RASSF6 NYNRIN HYDIN DNAH11	1.02e-03	713	172	12	EFO_0005689
Disease	susceptibility to scarlet fever measurement	SDK2 HLA-DRA FRYL CUL5	1.19e-03	79	172	4	EFO_0008409
Disease	skin pigmentation measurement	GABRG3 HLA-DRA SLC24A2 USH2A HYDIN	1.28e-03	137	172	5	EFO_0007009
Disease	osteonecrosis (is_implicated_in)	F5 TRPV4	1.47e-03	10	172	2	DOID:10159 (is_implicated_in)
Disease	creativity measurement	MAIP1 EPB41L2	1.47e-03	10	172	2	EFO_0010650
Disease	Autism Spectrum Disorders	RELN CHD2 TET1 USH2A	1.56e-03	85	172	4	C1510586
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	HMGCR ITGA1 INTS10 NR2C2AP NYNRIN DNAH11	1.69e-03	215	172	6	EFO_0008317, EFO_0008591
Disease	Myoclonic Astatic Epilepsy	CHD2 STXBP1	1.79e-03	11	172	2	C0393702
Disease	apolipoprotein B measurement	PGS1 HLA-DRA SNX17 HMGCR ITGA1 ZNF285 NYNRIN PLEC HYDIN CCDC93 DNAH11	1.84e-03	663	172	11	EFO_0004615
Disease	liver fat measurement	OLFM4 RASSF6 PLEC	2.02e-03	43	172	3	EFO_0010821
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	AGTR2 LRP1	2.15e-03	12	172	2	DOID:3827 (implicated_via_orthology)
Disease	autistic disorder (is_marker_for)	RELN GABRA4	2.15e-03	12	172	2	DOID:12849 (is_marker_for)
Disease	cortical surface area measurement	RELN NBEAL1 BAZ2B FAT3 DAPK1 FRYL HMGCR DYSF DNAH7 SNX13 MTMR11 NFIX UHRF1 ROBO2 PLEKHM3 HAS3 DNAH11	2.31e-03	1345	172	17	EFO_0010736
Disease	urate measurement	SFMBT1 INHBC SNX17 DYSF EVX2 TBC1D8 ANO6 RRP9 LRP1 UHRF1 EMX2 EPB41L2 RASGRP2	2.35e-03	895	172	13	EFO_0004531
Disease	total lipids in small LDL	SNX17 HMGCR NYNRIN	2.61e-03	47	172	3	EFO_0022168
Disease	Adenoid Cystic Carcinoma	DAPK1 SETD2 UHRF1 TOP2A	2.83e-03	100	172	4	C0010606
Disease	Disease Exacerbation	ABCA13 NBAS RRP9 MKI67 TOP2A	2.88e-03	165	172	5	C0235874
Disease	malignant pleural mesothelioma (is_marker_for)	SETD2 EMX2	2.94e-03	14	172	2	DOID:7474 (is_marker_for)
Disease	Autosomal recessive limb-girdle muscular dystrophy	DYSF PLEC	2.94e-03	14	172	2	cv:C2931907
Disease	phospholipids in medium LDL measurement	HMGCR ITGA1 NYNRIN	2.95e-03	49	172	3	EFO_0022183
Disease	cholesterol in medium LDL measurement	SNX17 HMGCR NYNRIN	2.95e-03	49	172	3	EFO_0022224
Disease	Liver carcinoma	CYP4A11 ACOX1 HMGCR BUB1B MKI67 UHRF1 HSPA5 TOP2A HERC5	3.03e-03	507	172	9	C2239176
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	PGS1 SNX17 NYNRIN DNAH11	3.04e-03	102	172	4	EFO_0004329, EFO_0004611
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	OTOA PCDH15 ATP2B2	3.30e-03	51	172	3	cv:CN043650
Disease	unipolar depression, autism spectrum disorder	OLFM4 SORCS3	3.37e-03	15	172	2	EFO_0003756, EFO_0003761
Disease	total lipids in LDL measurement	HMGCR ITGA1 NYNRIN	3.49e-03	52	172	3	EFO_0022308
Disease	remnant cholesterol measurement	SNX17 HMGCR NR2C2AP NYNRIN	3.73e-03	108	172	4	EFO_0010815
Disease	ankle brachial index	NBAS DMD	3.84e-03	16	172	2	EFO_0003912
Disease	Ciliopathies	NPHP1 PCDH15 USH2A DNAH11	3.98e-03	110	172	4	C4277690
Disease	phenylalanine measurement	TRPC3 PCDH15 ATP2B2	4.09e-03	55	172	3	EFO_0005001
Disease	very low density lipoprotein cholesterol measurement	SNX17 HMGCR INTS10 NR2C2AP NYNRIN DNAH11	4.31e-03	260	172	6	EFO_0008317
Disease	response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant	HSP90AB2P DMD	4.34e-03	17	172	2	EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	PGS1 HMGCR ITGA1 SNX13 INTS10 SLC9B1	4.64e-03	264	172	6	EFO_0008317, EFO_0020944
Disease	antihyperlipidemic drug use measurement	HLA-DRA HMGCR RASSF6 DNAH11	4.67e-03	115	172	4	EFO_0803367
Disease	phospholipids in LDL measurement	HMGCR ITGA1 NYNRIN	4.75e-03	58	172	3	EFO_0022294
Disease	phospholipids in small LDL measurement	HMGCR ITGA1 NYNRIN	4.98e-03	59	172	3	EFO_0022297
Disease	total blood protein measurement	PGS1 TRPC4AP ITGA1 DYSF SNX13 SETD2 NYNRIN HYDIN	4.99e-03	449	172	8	EFO_0004536
Disease	lung disease severity measurement	GABRG3 TMEM132C AGTR2 PCDH15	5.11e-03	118	172	4	EFO_0007744
Disease	HMG CoA reductase inhibitor use measurement	HMGCR ITPR3 SETD2 PLEC DNAH11	5.11e-03	189	172	5	EFO_0009932
Disease	hydrocephalus (implicated_via_orthology)	L1CAM HYDIN	5.41e-03	19	172	2	DOID:10908 (implicated_via_orthology)
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	HMGCR ITGA1 NYNRIN DNAH11	5.42e-03	120	172	4	EFO_0004611, EFO_0004639
Disease	colorectal cancer (is_implicated_in)	SETD2 BUB1B MKI67 EMX2	5.58e-03	121	172	4	DOID:9256 (is_implicated_in)
Disease	sleep duration, high density lipoprotein cholesterol measurement	PGS1 LILRB2 SNX13 INTS10	5.58e-03	121	172	4	EFO_0004612, EFO_0005271

Protein segments in the cluster

Peptide	Gene	Start	Entry
FWVAPRNSAELTVIK	BUB1B	781	O60566
NQVIFWLSFLKSLVP	DAPK1	851	P53355
PQRLTWLTVSTVFQR	HTR2B	256	P41595
AVLFAWNQRPREKIS	CUL5	601	Q93034
TLTEKNRQWFSLLPR	BAZ2B	1551	Q9UIF8
SLWQEIPVVRNSTVL	ARHGEF5	1151	Q12774
NLPETTIKVWFQNRR	EVX1	221	P49640
NLPETTIKVWFQNRR	EVX2	226	Q03828
ATGIPVTTWRFTNIK	FERMT1	596	Q9BQL6
QQKLRSVFRVPITWL	AGTR2	326	P50052
VPTGTRQQLIATWVK	CFAP46	851	Q8IYW2
LQPRVTLEQISAFWK	C16orf54	201	Q6UWD8
ELQRIQKWVETFPSA	CYP4A11	71	Q02928
LISQKVVSPQAFTWL	DNAH11	1816	Q96DT5
LTKYWQQIPLTDQSV	ABCA13	2896	Q86UQ4
RYVSLPNQNKIWTVT	ABHD4	46	Q8TB40
IRTWVQQSETKLSIP	DMD	951	P11532
SKRQVLRSPQWEVVD	DNHD1	1186	Q96M86
FPIQWETVSIFTRKH	CBLL2	221	Q8N7E2
VVPLSTLTSWQREIQ	CHD1	536	O14646
VFKVARQLQPSVVWI	IQCA1	621	Q86XH1
VWGQVIATIPTSRLK	ATP2B2	1076	Q01814
SESPVWVKLSQIQIQ	NBEAL1	1561	Q6ZS30
RQDFLPWKSLASIVQ	MTA2	291	O94776
PSWIFINEKTFITRE	RASSF6	41	Q6ZTQ3
VNEKRFPTWRKFLQT	IQCH	721	Q86VS3
QELVTPVKFARLWTE	ITPR3	791	Q14573
TEKSSQIVDPWERLF	INTS10	246	Q9NVR2
SLVIIPKNWSLFAVN	MPC2	86	O95563
VDAWKLTTQFRRLVP	ANO6	701	Q4KMQ2
TLPTKEFLWAVFQSV	OTOA	796	Q7RTW8
SIPITFLRNVTWVIV	KPNA3	211	O00505
TIRVNRQPTTWEKIF	nan	1026	O00370
VWNVTELVRVSQTPV	NFIX	221	Q14938
IPTAIDFTLWRQSIK	MAGEA5P	71	P43359
SNPINWVRTRIKAFL	MAIP1	116	Q8WWC4
IEINNWRSFIPSKAV	EYS	2041	Q5T1H1
IIFNLKSTFTEPVLW	NLRC4	126	Q9NPP4
IDSVPTYKWKRQVTQ	RASGRP2	121	Q7LDG7
LFIPWTNQKIRKTFV	INTS11	281	Q5TA45
RTITGFQSLIQKEWV	MTMR10	426	Q9NXD2
TLTFLRNTPWERGKQ	MTMR11	471	A4FU01
NRLTVVSKSVFLNWP	LRIT2	161	A6NDA9
KTKPIWTRNTEDITQ	HSP90AB2P	206	Q58FF8
NVSKRIEPSVSLWQF	HMGCR	296	P04035
FFVQLPSNTTWTLKV	INHBC	136	P55103
PSNTTWTLKVRVLVL	INHBC	141	P55103
TERVVLVNVSISWPN	LRP1	2041	Q07954
WRSLIPVIKVNVSTG	KIAA1109	196	Q2LD37
EWEKRRITPLSLQTQ	EPB41L2	666	O43491
APVVTNVTVKARVWN	ITGA3	921	P26006
PDVVSFRSTWVKRIQ	PDE1B	476	Q01064
SATFEQPSRQVKLWV	PGS1	531	Q32NB8
FETREALPTWDKQIQ	COPS4	361	Q9BT78
WSTRTLLNITKEQVP	CES4A	381	Q5XG92
VAQVKAFRSLWPSDI	FRYL	2921	O94915
LTTLQWRQEKAPQTV	MEGF8	1601	Q7Z7M0
SASWITRIRPELVKN	LILRB2	66	Q8N423
RKPLNNTVELTDVWT	LY75	341	O60449
VEFTNPLKETLRNVW	F13A1	651	P00488
SSAVLVKWRPVDLAQ	L1CAM	826	P32004
VSFWINKESVPARTV	GABRA4	276	P48169
ILSQVSFWINKESVP	GABRA6	256	Q16445
VSTWTQRSPLFKDVV	FGD3	261	Q5JSP0
NEPFLTLWLTQVERK	MKI67	441	P46013
QVDWRVVLKTTPLQQ	PLEKHM3	156	Q6ZWE6
ETPRFTVLNQTWVLK	CYHR1	251	Q6ZMK1
QVNVSLILWKPTFIK	ITGA1	1081	P56199
RTEAILKASWPQRQV	NBAS	2131	A2RRP1
ITRPVVLKWSVTQAL	PLCXD1	76	Q9NUJ7
NVASFRSWKRIPVVV	MTMR4	206	Q9NYA4
VLLPQKTWSSATRFR	RELN	996	P78509
VSDTFNKWTRITLPL	RELN	2431	P78509
RTIPTLNEGTVKRWI	HERC5	386	Q9UII4
ISNNWESLVVPFAKV	HERC5	501	Q9UII4
FQVIKNSPLSEWLIR	NCOA4	486	Q13772
PREKIQRLWSQSVSL	PCDH15	1566	Q96QU1
QEFILNSPTVTSIKW	ACOX1	161	Q15067
IFPVVQWLVKRAIET	CCDC93	116	Q567U6
LEFTNWKTLAPAVER	ASB3	426	Q9Y575
TNWLNKPQRFRVIVE	HYDIN	4751	Q4G0P3
TQKVPFIINTLWDAL	BTAF1	466	O14981
IWIPDTIFRNSKTAE	GABRG3	126	Q99928
RPNTSEILRTLTVWK	EIF2AK2	526	P19525
FLIVVPLSTLTSWQR	CHD2	536	O14647
SKVVLWAESRLPRQT	CRYBG2	1596	Q8N1P7
VSQIFWTKEVQTAIP	DNAH7	1186	Q8WXX0
TVDTLRILPSQNVWF	FAT3	2726	Q8TDW7
VVNVTWLRNGKPVTT	HLA-DRA	141	P01903
SRPVLNLIFDSEWVK	MDH1B	341	Q5I0G3
LVANVKQRAAWFRTP	MAN2B2	266	Q9Y2E5
TETPTKYLRWLNQQT	HAS3	341	O00219
INRWRIATKQASPEE	EMX2	231	Q04743
FRIPLVAKISSSWNI	CCDC168	7046	Q8NDH2
LEINDFPQTARWKVT	DDX46	936	Q7L014
RTWNDPSVQQDIKFL	HSPA5	101	P11021
STVERRAINLTWTKP	SDK2	601	Q58EX2
SLKPSNVTVDVFVQW	SLC19A3	251	Q9BZV2
VKNTLNPTWDQTLIF	DYSF	1191	O75923
QPLTVFVELWLKNRT	PRAMEF26	51	H0Y7S4
IRELASTTQIDFWKP	CPB1	41	P15086
SKFTQISPVWLQLKR	CHID1	101	Q9BWS9
VLKWRLQTTEESFIP	ARCN1	361	P48444
AVTPFLTKLWQETVQ	KCNE1B	11	A0A087WTH5
ITSRTPQWKKNRVTV	KBTBD6	571	Q86V97
KVLSNIHTVRATWQP	NPHP1	416	O15259
SQWVTLEFPQLIRVS	NR2C2AP	46	Q86WQ0
EVTVFVPTWQLKKNR	NYNRIN	831	Q9P2P1
EVSKWENPRVLSFSL	OAS3	861	Q9Y6K5
TFQELIQEAKPRATW	RTP4	11	Q96DX8
PVTLELTKVWRQADQ	PIF1	371	Q9H611
LIQFATRSKEIDWQP	SNX13	141	Q9Y5W8
VKLWKAFTVVQPTFR	TSEN2	326	Q8NCE0
ITSRSLQIDWVSPRK	USH2A	3121	O75445
SRSWNELPKIVVVQS	SPHKAP	441	Q2M3C7
PSVFTVFQKIWLTAL	SLC29A2	281	Q14542
WKETVSILLNPDRQS	TRPC4AP	761	Q8TEL6
LFQKITWPQVLSGVV	SLC47A2	211	Q86VL8
ELSQIKGWRVPIVTN	TMEM132C	536	Q8N3T6
VLRTPKQEAVFSTWL	TMEM132C	701	Q8N3T6
IISRFIRVIPKTWNQ	F5	2196	P12259
LAWPSETRKQVTFLI	SLC24A2	461	Q9UI40
IRNKEVNISAVVWPS	SORCS3	926	Q9UPU3
ILWQAEQPVSQTTTL	PTGIS	316	Q16647
RTRALWVISKQTFPS	RIF1	116	Q5UIP0
FLQAATPKERTEWIR	PLEK	326	P08567
PVTLWTGKQIFSVIL	POLR3A	591	O14802
TAITATNPIWLIKTR	SLC25A36	131	Q96CQ1
FRKPAVWAAVVSQLS	SLC17A9	236	Q9BYT1
FAALTPVWVLIAKQS	SLC41A3	261	Q96GZ6
IWNVSRTTPIDNLKL	WDR17	296	Q8IZU2
KPVVIRASKQWFINI	IARS2	471	Q9NSE4
QQDFLPWKSLTSIIE	MTA1	311	Q13330
QTYQLSRWTPIIKDI	STXBP1	471	P61764
VVNISKPSVVQLNWR	OLFM4	251	Q6UX06
VRNAFWLQITEKLTP	RIG	51	Q13278
SSAVIPVLRKTLWRQ	URB1	1291	O60287
NLWREETTTNVKTPL	OMG	401	P23515
PRLNRVWKQFTIASE	SESTD1	581	Q86VW0
FWSQRVEDSKINIPT	TET1	191	Q8NFU7
QIPESLKSITWQRLG	ABCB7	56	O75027
ETLEWSKNVFRVPVL	ACSS3	431	Q9H6R3
TKLEEFIQWLLSRPT	CCDC54	266	Q8NEL0
TKSTWPQKRTLFVLN	RRP7A	51	Q9Y3A4
DIKNRLPRSVTTVQW	PRPF8	1156	Q6P2Q9
KDRLQWVTITSPQAI	SNX17	356	Q15036
NLASVEWEIQPRTKR	ZNF561	76	Q8N587
PTRVIVVWFQNARQK	ZFHX4	2221	Q86UP3
VLEWLFISQEQPKIT	ZNF268	61	Q14587
QFLTILPGEVRTWVK	ZNF287	96	Q9HBT7
SSFQNITEKWLPEIR	RHOV	116	Q96L33
VQLTNFSLVPVQWRT	MPV17L	136	Q2QL34
TVRVWKIPEESQLVF	RRP9	306	O43818
RNIERLKPSLQFVSW	TUBE1	361	Q9UJT0
AVITWEVLSRKQPFE	RIPK2	216	O43353
PWVDIQKLERTSNVF	TBC1D8	201	O95759
TLFWSKLQQRVEPSI	ZNF292	296	O60281
VQSLSLPRWRESFIV	VIT	121	Q6UXI7
TLEKWVTEIFSQIPN	NRDC	391	O43847
RVIQGTTTLLPQWDK	PHEX	391	P78562
TVQVTWTVDRQPQFI	ROBO2	651	Q9HCK4
LPNQTVLKIWDSVFF	TBC1D30	441	Q9Y2I9
EWAQKVLSQPFDTVL	RFX7	131	Q2KHR2
WSIKPDTVQVIRTQN	PKHD1L1	576	Q86WI1
QKIITTVWDIFQPLL	SLC9B1	366	Q4ZJI4
KQVDSIVWTFNTTPL	SLAMF7	46	Q9NQ25
WSLATFRTLKPEEQR	PLEC	1046	Q15149
DTELQPVKTFWILIQ	ZCCHC10	16	Q8TBK6
EESKVLPIIQRWSQT	SETD2	1816	Q9BYW2
TAKFRNWINETILVP	TMEM209	336	Q96SK2
SVWQISLQKFPILVV	ZNFX1	641	Q9P2E3
LPVRTWTQTYKEQVL	TOP2A	926	P11388
WFEAQVVRVTRKAPS	UHRF1	151	Q96T88
TLTVQIFKDDWIRPA	SLC30A6	326	Q6NXT4
LWPEQNIRDSFQKVT	ZNF117	21	Q03924
SNPLKWSVADVVRFI	SFMBT1	791	Q9UHJ3
LKSVSLQEPRSRWQE	RHBDF2	86	Q6PJF5
NITKQTPSFWILARA	NAE1	296	Q13564
RQDVNITVATVPSWL	PTK7	401	Q13308
VIKDFVLTWLENRPS	UGT2A1	86	P0DTE4
STTLAEKTWVQLFPR	TRRAP	2621	Q9Y4A5
RWSSVVPRVVELNKN	TRPV4	821	Q9HBA0
LFTLQQTRWLPVSKA	TMEM38A	196	Q9H6F2
QTRWLPVSKASLIFI	TMEM38A	201	Q9H6F2
LTQVLTPESWRKANI	ZNF285	141	Q96NJ3
PKQIFRVKTTQFTWT	TRPC3	411	Q13507
FTQKEWRLLSPAQRA	ZNF337	21	Q9Y3M9
NTFRTVPIEQKHEVW	N4BP1	461	O75113